Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] Statement Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Short-Term Investments Short-term investments Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Prepaid expenses and other current assets Assets, Current Total current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities Liabilities, Current Total current liabilities Liabilities Total liabilities Commitments and Contingencies Commitments and Contingencies (Note 15) Equity, Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock Common Stock, Value, Issued Common stock, $0.001 par value; 1,500,000,000 and 120,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 19,339,786 and 556,995 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively * Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Equity, Attributable to Parent Balance as of end of period Balance as of beginning of period Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Class of Stock [Axis] Class of Stock [Domain] Represents information relating to non-redeemable, non-controlling series E preferred stock. Series E Non Redeemable Non Controlling Preferred Stock [Member] Series E Convertible Non-Redeemable Preferred Stock Represents information relating to non-redeemable, non-controlling series F preferred stock. Series F Non Redeemable Non Controlling Preferred Stock [Member] Series F Convertible Non-Redeemable Preferred Stock Represents information relating to non-redeemable, non-controlling series G preferred stock. Series G Non Redeemable Non Controlling Preferred Stock [Member] Series G Convertible Non-Redeemable Preferred Stock Represents information relating to non-redeemable, non-controlling series H preferred stock. Series H Non Redeemable Non Controlling Preferred Stock [Member] Series H Convertible Non-Redeemable Preferred Stock Represents information pertaining to series AA convertible non redeemable preferred stock. Series Aa Convertible Non Redeemable Preferred Stock [Member] Series AA preferred stock Series AA Convertible Non-Redeemable Preferred Stock Temporary Equity, Shares Outstanding Balance as of end of period (in shares) Balance as of beginning of period (in shares) Redeemable preferred stock, outstanding Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock split CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Operating Expenses [Abstract] Costs and expenses: General and Administrative Expense General and administrative Research and Development Expense Research and development Amount of (gain) loss recognized on fair value adjustment of contingent consideration. (Gain) Loss on Fair Value Re-measurement of Contingent Consideration Loss on fair value remeasurement of contingent consideration Loss on fair value remeasurement of contingent consideration Operating Expenses Total costs and expenses Operating Income (Loss) Loss from operations Other Income and Expenses [Abstract] Other income (expense): Investment Income, Interest Interest income Interest Expense, Nonoperating Interest expense Amount of grant income. Income From Grants Grant income Other Nonoperating Income (Expense) Other income (expense), net Nonoperating Income (Expense) Total other income (expense) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Net loss and comprehensive loss Earnings Per Share, Basic Net loss per share attributable to common stockholders-basic (in dollar per share) Net loss per share attributable to common stockholders, basic Earnings Per Share, Diluted Net loss per share attributable to common stockholders-diluted (in dollar per share) Net loss per share attributable to common stockholders, diluted Weighted Average Number of Shares Outstanding, Basic Weighted average shares outstanding-basic (in shares) Weighted-average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average common shares outstanding -diluted (in shares) Weighted-average common shares outstanding, diluted (in shares) CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Equity Components [Axis] Equity Component [Domain] Preferred Stock [Member] Preferred Stock Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Represents information relating to non-redeemable, non-controlling series I preferred stock. Series I Non Redeemable Non Controlling Preferred Stock [Member] Series I Convertible Non-Redeemable Preferred Stock Represents information pertaining to non-redeemable, non-controlling series AA preferred stock. Series Aa Non Redeemable Non Controlling Preferred Stock [Member] Series AA Convertible Non-Redeemable Preferred Stock Represents information pertaining to non-redeemable, non-controlling series AAA preferred stock. Series Aaa Non Redeemable Non Controlling Preferred Stock [Member] Series AAA Convertible Non-Redeemable Preferred Stock Temporary Equity [Abstract] Mezzanine equity: Increase (Decrease) in Stockholders' Equity [Roll Forward] Stockholders' Equity Shares, Outstanding Balance as of end of period (in shares) Balance as of beginning of period (in shares) Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock under employee stock purchase plan Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock under employee stock purchase plan (in shares) Stock Issued During Period, Value, Issued for Services Issuance of common stock to satisfy service contract Stock Issued During Period, Shares, Issued for Services Issuance of common stock to satisfy service contract (in shares) Number of new stock issued during the period from the conversion of Series E Preferred Stock. Stock Issued During Period Shares New Issues Conversion Of Preferred Stock Conversion of Preferred Stock Number of new stock shares issued during the period from the conversion of Preferred Stock. Stock Issued During Period Shares New Issues Shares Conversion Of Preferred Stock Conversion of Preferred Stock (in shares) Equity impact of the value of stock that has been retired during the period. Stock Retired During Period, Value Retired shares Number of shares that have been retired during the period. Stock Retired During Period, Shares Retired shares (In shares) Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Issuance of common stock for vested restricted stock units Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of common stock for vested restricted stock units (in shares) Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments Issuance of Series AAA Preferred Stock Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of Series AAA Preferred Stock (in shares) Stock Issued During Period, Value, New Issues Aggregate market value Issuance of Common Stock, net of issuance cost Stock Issued During Period, Shares, New Issues Stock offering, net of issuance cost and underwriting fees (in shares) Number of shares issued APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Amount of non-cash operating lease cost. Non Cash Operating Lease Non-cash operating lease cost Amortization of Debt Issuance Costs and Discounts Amortization of debt discount and other non-cash interest Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Issuance of Stock and Warrants for Services or Claims Issuance of Common Stock for service contract Increase (Decrease) in Operating Capital [Abstract] Change in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Noncurrent Assets Other long-term assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued expenses and other current liabilities The increase (decrease) during the reporting period in lease and noncurrent liabilities. Increase Decrease In Lease And Other Liabilities, Noncurrent Lease liabilities and other long-term liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: The cash outflow associated with the acquisition of long-lived, physical and other assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Payments To Acquire Property Plant And Equipment And Other Assets Payment for short-term investment Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: The cash outflow for cost incurred directly with the issuance of common and preferred stock. Payments Of Common Stock And Preferred Issuance Costs Payment of issuance costs from issuance of common stock and Series I preferred stock Proceeds from Issuance of Convertible Preferred Stock Proceeds from issuance of Series AAA preferred stock, net of issuance cost The amount of cash outflow of principal on venture debt facility. Payment of Principal on Venture Debt Facility Payment of principal and payment fee on debt Proceeds from Issuance of Common Stock Gross proceeds Finance Lease, Principal Payments Payment of principal on finance lease Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Proceeds from issuance of common stock under employee stock purchase plan Net Cash Provided by (Used in) Financing Activities Net cash provided by (used in) financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (decrease) increase in cash and cash equivalents: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non-cash investing and financing activities: Issuance of common stock to satisfy deferred purchase consideration in additional paid-in capital. Issuance of common stock to satisfy deferred purchase consideration in additional paid-in capital Issuance of common stock to satisfy service contract in additional paid-in capital Supplemental Cash Flow Information [Abstract] Supplemental disclosure: Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest NATURE OF BUSINESS AND BASIS OF PRESENTATION Business Description and Basis of Presentation [Text Block] NATURE OF BUSINESS AND BASIS OF PRESENTATION SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES FAIR VALUE OF FINANCIAL INSTRUMENTS Fair Value Disclosures [Text Block] FAIR VALUE OF FINANCIAL INSTRUMENTS No definition available. LICENSE AGREEMENT Collaborative Arrangement Disclosure [Text Block] LICENSE AGREEMENT SHORT-TERM INVESTMENT The entire disclosure of short-term investment. Short Term Investments [Text Block] SHORT-TERM INVESTMENT n/a. GRANT INCOME The entire disclosure of grant income. Grant Income [Text Block] GRANT INCOME PREPAID EXPENSES AND OTHER CURRENT ASSETS Other Current Assets [Text Block] PREPAID EXPENSES AND OTHER CURRENT ASSETS ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES No definition available. PRIVATE PLACEMENTS The entire disclosure of private placement. Private Placement [Text Block] PRIVATE PLACEMENTS WARRANTS The entire disclosure for information about stock warrants. Stock Warrants [Text Block] WARRANTS REGISTERED OFFERINGS Equity [Text Block] REGISTERED OFFERINGS STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] STOCK-BASED COMPENSATION LOSS PER SHARE Earnings Per Share [Text Block] LOSS PER SHARE INCOME TAXES Income Tax Disclosure [Text Block] INCOME TAXES COMMITMENTS AND CONTINGENCIES. Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES SEGMENT Segment Reporting Disclosure [Text Block] SEGMENT SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of prepaid expenses and other current assets Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of outstanding warrants Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stock-based compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock based compensation expense Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net loss per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of outstanding securities excluded from the computation of diluted weighted average shares outstanding as they would have been anti-dilutive Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Schedule of segment expenses, other segment items and a reconciliation to net loss Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to November 2025 securities purchase agreement. Securities Purchase Agreement, November 2025 [Member] Securities Purchase Agreement November 2025 Represents information pertaining to January 2026 securities purchase agreement. Securities Purchase Agreement, January 2026 [Member] Securities Purchase Agreement January 2026 Represents information pertaining to series AAA convertible non redeemable preferred stock. Series Aaa Convertible Non Redeemable Preferred Stock [Member] Series AAA Convertible Non-Redeemable Preferred Stock Subsidiary, Sale of Stock [Line Items] EQUITY FINANCINGS PRIVATE PLACEMENTS Number of closings. Number Of Closings Number of closings Preferred Stock, Convertible, Conversion Ratio Number of common shares issuable upon conversion for each share of preferred stock Preferred Stock, Convertible, Shares Issuable Number of common shares issuable upon conversion of preferred stock Preferred Stock, Capital Shares Reserved for Future Issuance Preferred stock, capital shares reserved for future issuance Share Price Price per share Amount of proceeds receivable from preferred stock reserved for future issuance. Proceeds From Preferred Stock Reserved For Future Issuance Proceeds from preferred stock reserved for future issuance Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents information pertaining to Platform Development and Exclusive License Agreement. Platform Development And Exclusive License Agreement [Member] Platform Development and Exclusive License Agreement Counterparty Name [Axis] Counterparty Name [Domain] Represents information pertaining to Younet AI anOntario corporation. Younet [Member] Younet Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] LICENSE AGREEMENT Represents initial term of the license agreement. License Agreement, Initial Term Initial term (in months) Represents renewal term of the license agreement. License Agreement, Renewal Term Renewal term (in months) Amount of maximum cash fees agreed to pay for the initial term under the terms of the license agreement. License Agreement, Maximum Cash Fees Maximum cash fees The cash outflow associated with payment of cash fees under the terms of the license agreement.. License Agreement, Payment Of Cash Fees Cash fees paid in cash Amount of cash fees payable under the terms of the license agreement. License Agreement, Cash Fees, Amount Payable Cash fees payable Represents the total number of monthly installment payments required under the terms of the license agreement. License Agreement, Cash Fees, Number Of Payment Installments Number of installments Amount of fixed monthly installment payment amount due under the terms of the license agreement. License Agreement, Cash Fees, Amount Of Payment Installments Amount of payment installment Represents the notice period of termination of the continued development under the license agreement. License Agreement, Termination Notice Period Termination notice period (in days) Represents the period within which the Company is required to issue common stock for renewal term. License Agreement, Share Issuance Period, Renewal Period Share issuance period, renewal term (in days) Amount of cash to be paid by the Company upon each extension of the Agreement for a Renewal Term. License Agreement, Cash Payment Amount, Renewal Term Cash payment, renewal term Number of common stock shares agreed to be issued during the renewal period under the license agreement. License Agreement, Shares Agreed To Issue, Renewal Term Shares agreed to issue in renewal term (in shares) Represents the maximum percentage of the Daily Trading Volume that is permitted to sell Shares on any Trading Day pursuant to the terms of the License Agreement. License Agreement, Maximum Daily Trading Volume Percentage Maximum percentage of daily trading volume (in percent) Represents the purchase price for option to acquire either all equity interests or all assets . License Agreement, Option to Acquire Equity Interests or All Assets, Purchase Price Purchase price Accounts and Financing Receivables [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Secured Debt [Member] Secured debt Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable Debt Instrument, Face Amount Aggregate principal amount Debt Instrument, Interest Rate, Stated Percentage Interest rate (as a percent) Period of time allowed for the borrower to make a required payment after receiving a notice of default under a financing receivable, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Financing Receivable, Grace Period To Make Payment Financing receivable, grace period to make payment Annual interest rate applied to a financing receivable in case of default. Financing Receivable, Default Interest Rate, Percentage Financing receivable, default interest rate, percentage Interest Expense, Subordinated Notes and Debentures Interest paid Long-Term Debt, Gross Outstanding principal Discloses pertinent information about grant income Grant Income [Table] Legal Entity [Axis] All Entities [Member] Represents information relating to Combangio, Inc. Combangio Inc [Member] Combangio, Inc. Represents the information pertaining to Award Agreement Member. Award Agreement [Member] Award agreement Represents the information pertaining to California Institute for Regenerative Medicine Member. California Institute for Regenerative Medicine [Member] California Institute for Regenerative Medicine (CIRM) Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Grant Income [Line Items] Grant Income Other Restricted Assets Restricted grant Deferred Income, Current Deferred grant income Prepaid Insurance Insurance Amount of asset related to consideration paid in advance for licenses that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Prepaid Licenses Prepaid License Agreement - Younet Interest Receivable, Current Interest Receivables Other Prepaid Expense, Current Other Accrued Professional Fees, Current Professional services Carrying values as of the balance sheet date of payable towards development costs, due within one year or within the normal operating cycle if longer. Development Costs, Current Development costs Accrued revenue reserves. Accrued revenue reserves Accrued revenue reserves (1) Employee-related Liabilities, Current Compensation and benefits Other Accrued Liabilities, Current Other Represents information pertaining to series AA and series AAA convertible non redeemable preferred stock. Series Aa Convertible Non Redeemable Preferred Stock And SeriesAaa Convertible Non Redeemable Preferred Stock [Member] Series Aa Convertible Non-Redeemable Preferred Stock And Series Aaa Convertible Non-Redeemable Preferred Stock Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents information pertaining to Warrant 2016. Warrants 2016 [Member] Warrants 2016 Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise Price of warrant Number of warrants or right exercisable. Class of Warrant or Right, Exercisable Shares Exercisable Stock, Class of Stock [Table] Represents information pertaining to December 2025 Registered Direct Offering. December 2025, Registered Direct Offering [Member] December 2025 Registered Direct Offering Represents information pertaining to May 2026 Shelf Registration Statement. May 2026 Shelf Registration Statement [Member] May 2026 Shelf Registration Statement Class of Stock [Line Items] REGISTERED OFFERINGS Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of pre-funded warrants issued Purchase price per share or per unit of warrants or rights. Class of Warrant or Right, Purchase Price Pre-funded warrant purchase price Class of warrant right beneficial ownership limitation percentage to exercise warrants. Class Of Warrant or Right, Beneficial Ownership Limitation, Percentage to Exercise Warrants Ownership limitation percentage Class of warrant right maximum beneficial ownership limitation percentage to exercise warrants upon election of holder. Class Of Warrant or Right, Maximum Beneficial Ownership Limitation, Percentage to Exercise Warrants Upon Election of Holder Maximum ownership limitation percentage Threshold number of prior notice period required to increase the beneficial ownership interest limit. Class of Warrant or Right, Threshold Prior Notice Period for Increasing Beneficial Ownership Limit Threshold prior notice period Threshold number of restricted period for issuance of new shares. Issuance Restriction Period Post Offering Issuance restriction period Threshold restriction period for variable rate transaction issuance. Variable Rate Transaction Issuance Restriction Period Post Offering Variable rate transaction issuance restriction period Represents the maximum offering value of a variety of securities offered under the shelf registration. Shelf Registration, Maximum Offering Value Shelf registration maximum offering value Plan Name [Axis] Plan Name [Domain] Represents information pertaining to Amended and Restated 2017 equity incentive plan. Amended And Restated Equity Incentive Plan 2017 [Member] 2017 Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Number of additional shares authorized for issuance under share-based payment arrangement Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Shares authorized Represents the annual limit on non-employee director compensation for incumbent directors. Annual Limit On Non-Employee Director Compensation For Incumbent Directors Annual limit on non-employee director compensation for incumbent directors Represents the annual limit on non-employee director compensation for director's first year of service. Annual Limit On Non-Employee Director Compensation For Director's First Year Of Service Annual limit on non-employee director compensation for director's first year of service Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Options expiry term The annual increase in the number of shares. Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Annually, Percent Annual increase in the number of shares (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of shares available for future issuance Options to purchase shares of common stock Restricted Stock Units (RSUs) [Member] RSU Represents information pertaining to employee stock purchase plan. Employee Stock Purchase Plan [Member] ESPP Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted, other than options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding balance (in shares) Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Expense Stock based compensation expense Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Numerator: Net Income (Loss) Available to Common Stockholders, Basic Net loss Net loss attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Diluted Net loss attributable to common stockholders, diluted Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions or target is met. Unvested Restricted Stock Units [Member] Unvested RSUs Warrant [Member] Unexercised warrants Convertible Preferred Stock [Member] Convertible preferred stock (as converted to common stock) Convertible preferred stock (as converted to common stock) Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Outstanding securities excluded from the computation of diluted weighted average shares outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Outstanding securities excluded from the computation of diluted weighted average shares outstanding (in shares) Income Tax, Examination [Table] Income Tax Examination [Line Items] Income Taxes The annual limitation of the amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Tax Credit Carryforward, Amount Annual Limitation Annual limitation amount of tax credit carryforward Unrecognized Tax Benefits Uncertain tax positions Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Interest or penalties recorded Other Commitments [Table] Asset Acquisition [Axis] Asset Acquisition [Domain] Scenario [Axis] Scenario [Domain] Represents information pertaining to achievement of specified development and regulatory milestones relating to kpi-012. Scenario Achievement Of Specified Development And Regulatory Milestones Relating To K P I 012 Product [Member] Achievement of specified development and regulatory milestones relating to KPI-012 product Represents information pertaining to achievement of sales based milestone relating to kpi-012. Scenario Achievement Of Sales Based Milestone Relating To K P I 012 Product [Member] Achievement of sales based milestone relating to KPI-012 product Represents information relating to first patient dosed with any product in phase 2 clinical trail the "Dosing Milestone. First Patient Dosed With Any Product In Phase 2 Clinical Trial Dosing Milestone [Member] First patient dosed with any product in phase 2 clinical trial, dosing milestone Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Other Commitments [Line Items] Other Commitments Annual license maintenance fees owed to Stanford for specific regulatory milestones. Annual License Maintenance Fees Upon Achievement Of Specific Milestones Annual license maintenance fees owed to Stanford for specific regulatory milestones Potential payout for contingent consideration upon achievement of specified development , regulatory and commercial milestones. Potential Payout for Contingent Consideration, Upon Achievement of Specified Development Regulatory and Commercial Milestones Contingent upon specified development, regulatory and commercialization milestones Amount of contingent milestone consideration payable in cash in connection with asset acquisition. Asset Acquisition Contingent Milestone Consideration, Cash Paid Contingent milestone consideration paid Amount of acquirer's equity interest issued and issuable as part of contingent milestone consideration transferred in asset acquisition. Asset Acquisition Contingent Milestone Consideration, Equity Interest Issued OR Issuable Contingent milestone consideration paid in shares value Number of shares of acquirer's equity interest issued and issuable as part of contingent milestone consideration transferred in asset acquisition. Asset Acquisition Contingent Milestone Consideration, Number of Equity Interest Issued OR Issuable Contingent milestone consideration paid in shares Amount of contingent milestone consideration in connection with asset acquisition. Asset Acquisition Contingent Milestone Consideration Payable Contingent milestone consideration The amount of potential maximum payout for contingent consideration contingent upon the achievement of specified development, regulatory and sales-based milestones related to specified product. Potential Maximum Payout for Contingent Consideration Potential maximum payout for contingent consideration Amount of annual license maintenance fees paid under an license agreement. Annual License Maintenance Fee Annual license maintenance fee Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Segments [Axis] Segments [Domain] Represents the information pertaining to single reporting segment. Single Reporting Segment [Member] Single Reporting Segment Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Segment Information Number of Operating Segments Number of operating segments Number of Reportable Segments Number of reportable segments Costs and Expenses [Abstract] Costs and expenses: Amount of expense for research and development, attributable to product development costs. Research and Development Expense, Product Development Costs KPI012 development costs Amount of expense for research and development, attributable to employee related costs. Research and Development Expense, Employee Related Costs Employeerelated costs for research and development personnel Other Research and Development Expense Other research and development costs Segment Reporting, Other Segment Item, Amount Other segment expense (income), net Segment Reporting, Other Segment Item, Composition, Description Other segment expense, description Subsequent Event [Table] Subsequent Event [Line Items] SUBSEQUENT EVENTS